Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Cambridge Cognition Holdings Plc
COGCambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. It also offers eCOA, a data management tool for clinical scales which supports questionnaires and issue resolutions; and provides cognitive kit for detecting fluctuations in brain health. In addition, the company provides voice analysis tools for monitoring neurological and psychiatric disorders; eConsent, a patient consent solution; and Clinpal, an application for managing patients workflows. Further, it offers AQUA, a speech analysis platform for clinical scales. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom. Address: Tunbridge Court, Cambridge, United Kingdom, CB25 9TU
Analytics
Precio Objetivo de WallStreet
10 385.16 GBXRelación P/E
–Rentabilidad por dividendo
–Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave COG
Análisis de dividendos COG
Aumento del dividendo durante 5 años
–Crecimiento continuo
–Ratio de pago medio en 5 años
–Tendencia del payout COG
Valoración de la acción COG
Finanzas COG
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |